Literature DB >> 22141601

Oesophageal dilatation on high-resolution CT chest in systemic sclerosis: what does it signify?

Anoop Kumar Pandey1, Pearce Wilcox, John R Mayo, Robert Moss, Jennifer Ellis, Jacquie Brown, Arvind Kavishwar, Jonathon Leipsic.   

Abstract

OBJECTIVE: To evaluate the significance of oesophageal dilatation on high-resolution CT (HRCT) chest in patients with systemic sclerosis.
METHODS: We retrospectively retrieved the database of patients with systemic sclerosis seen at our hospital between January 2008 and January 2009. A total of 50 patients (46 women and four men) who had HRCT chest, pulmonary function testing and echocardiography within 1 month were included in the study. Peak pulmonary artery (PA) pressures and pulmonary function testing were charted. The HRCT chest was interpreted by a chest radiologist. Oesophageal dilatation was defined as a luminal coronal diameter of ≥9 mm in infra-aortic oesophagus. Extent of ground glass, reticulation and honeycombing was objectively scored.
RESULTS: Statistical analysis using independent t-test showed that diffusion capacity of carbon monoxide was significantly lower (P = 0.042) and peak PA pressures were significantly higher (P = 0.045) in patients with oesophageal dilatation (n = 29) as compared with those without oesophageal dilatation (n = 21). The two cohorts had no significant difference in their total lung capacity and HRCT determined extent of interstitial lung disease.
CONCLUSION: Patients with oesophageal dilatation on HRCT chest had significantly lower diffusion capacity of carbon monoxide and higher peak PA pressures, which suggest that these patients tend to have more severe pulmonary vascular disease.
© 2011 The Authors. Journal of Medical Imaging and Radiation Oncology © 2011 The Royal Australian and New Zealand College of Radiologists.

Entities:  

Mesh:

Year:  2011        PMID: 22141601     DOI: 10.1111/j.1754-9485.2011.02317.x

Source DB:  PubMed          Journal:  J Med Imaging Radiat Oncol        ISSN: 1754-9477            Impact factor:   1.735


  9 in total

1.  Relationship between interstitial lung disease and oesophageal dilatation on chest high-resolution computed tomography in patients with systemic sclerosis: a cross-sectional study.

Authors:  Fausto Salaffi; Marco Di Carlo; Marina Carotti; Paolo Fraticelli; Armando Gabrielli; Andrea Giovagnoni
Journal:  Radiol Med       Date:  2018-04-23       Impact factor: 3.469

Review 2.  Measuring response in the gastrointestinal tract in systemic sclerosis.

Authors:  Dinesh Khanna; Vivek Nagaraja; Heather Gladue; William Chey; Mark Pimentel; Tracy Frech
Journal:  Curr Opin Rheumatol       Date:  2013-11       Impact factor: 5.006

3.  Esophageal dilatation and interstitial lung disease in systemic sclerosis: A cross-sectional study.

Authors:  Carrie Richardson; Rishi Agrawal; Jungwha Lee; Orit Almagor; Ryan Nelson; John Varga; Michael J Cuttica; Jane D Amico Dematte; Rowland W Chang; Monique E Hinchcliff
Journal:  Semin Arthritis Rheum       Date:  2016-02-26       Impact factor: 5.532

4.  Comment on "Esophageal dilatation and interstitial lung disease in systemic sclerosis: A cross-sectional study".

Authors:  Aileen Hoffmann; Jungwha Lee; Madeleine Ma; Rishi Agrawal; Rowland W Chang; Carrie Richardson; Monique Hinchcliff; Kimberly Showalter
Journal:  Semin Arthritis Rheum       Date:  2016-05-06       Impact factor: 5.532

5.  Esophageal Dilatation as a Predictor of Systemic Sclerosis in Patients with Interstitial Lung Disease.

Authors:  Ana Filipa Santos Duarte de Figueiredo; João Felício Costa; António P Matos; Miguel Ramalho
Journal:  Turk Thorac J       Date:  2021-05

6.  Significance of various pulmonary and extrapulmonary abnormalities on HRCT of the chest in scleroderma lung.

Authors:  Anoop Kumar Pandey; Pearce Wilcox; Julie O' Brien; Jennifer Ellis; Jacquie Brown; Jonathon Leipsic
Journal:  Indian J Radiol Imaging       Date:  2013-10

7.  The Extrapulmonary Manifestations of Systemic Sclerosis on Chest High Resolution Computed Tomography.

Authors:  Donya Farrokh; Bita Abbasi; Yalda Fallah-Rastegar; Zahra Mirfeizi
Journal:  Tanaffos       Date:  2015

8.  The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial.

Authors:  George P Karamanolis; Stylianos Panopoulos; Konstantinos Denaxas; Anastasios Karlaftis; Alexandra Zorbala; Dimitrios Kamberoglou; Spiros D Ladas; Petros P Sfikakis
Journal:  Arthritis Res Ther       Date:  2016-09-01       Impact factor: 5.156

9.  Gastric Juice Expression of Th-17 and T-Reg Related Cytokines in Scleroderma Esophageal Involvement.

Authors:  Stefania Nicola; Giovanni Rolla; Caterina Bucca; Giada Geronazzo; Irene Ridolfi; Andrea Ferraris; Enrico Fusaro; Clara Lisa Peroni; Luca Dughera; Luisa Brussino
Journal:  Cells       Date:  2020-09-16       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.